Literature DB >> 21777932

HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genes.

Matthew D Marsden1, Bryan P Burke, Jerome A Zack.   

Abstract

We have previously described an in vitro primary thymocyte model for HIV latency that recapitulates several important aspects of latently infected cells obtained from patients. Our original model included a truncated HIV genome expressing only Tat, Rev, and Vpu along with a reporter gene. We have now expanded these studies to include reporter viruses encoding more complete viral genomes. We show here that regions of the viral genome outside of the long terminal repeat promoter and Tat/Rev regulatory genes can substantially affect both the basal level of HIV transcription prior to stimulation, and also the level of viral expression following costimulation via CD3 and CD28 ligation. These differences in latency phenotype between truncated and more complete HIV genomes demonstrate the importance of accessory genes in the context of HIV latency and indicate that care should be taken when interpreting data derived from heavily modified HIV genomes in latency models.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777932      PMCID: PMC3163716          DOI: 10.1016/j.virol.2011.06.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency.

Authors:  S Emiliani; C Van Lint; W Fischle; P Paras; M Ott; J Brady; E Verdin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency.

Authors:  Young Kyeung Kim; Cyril F Bourgeois; Richard Pearson; Mudit Tyagi; Michelle J West; Julian Wong; Shwu-Yuan Wu; Cheng-Ming Chiang; Jonathan Karn
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

4.  Molecular characterization, reactivation, and depletion of latent HIV.

Authors:  David G Brooks; Dean H Hamer; Philip A Arlen; Lianying Gao; Greg Bristol; Christina M R Kitchen; Edward A Berger; Jerome A Zack
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

5.  A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes.

Authors:  Gautam K Sahu; Kyeongeun Lee; Jiaxiang Ji; Vivian Braciale; Samuel Baron; Miles W Cloyd
Journal:  Virology       Date:  2006-08-17       Impact factor: 3.616

6.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

Authors:  L Naldini; U Blömer; F H Gage; D Trono; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

7.  Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.

Authors:  Deirdre D Scripture-Adams; David G Brooks; Yael D Korin; Jerome A Zack
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line.

Authors:  S Emiliani; W Fischle; M Ott; C Van Lint; C A Amella; E Verdin
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 9.  Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

10.  Long-term human hematopoiesis in the SCID-hu mouse.

Authors:  R Namikawa; K N Weilbaecher; H Kaneshima; E J Yee; J M McCune
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.

Authors:  Vicente Planelles; Frank Wolschendorf; Olaf Kutsch
Journal:  Curr HIV Res       Date:  2011-12-01       Impact factor: 1.581

2.  Mechanisms of HIV Transcriptional Regulation and Their Contribution to Latency.

Authors:  Gillian M Schiralli Lester; Andrew J Henderson
Journal:  Mol Biol Int       Date:  2012-06-03

3.  HIV Silencing and Inducibility Are Heterogeneous and Are Affected by Factors Intrinsic to the Virus.

Authors:  Nicholas J Norton; Hoi Ping Mok; Fatima Sharif; Jack C Hirst; Andrew M L Lever
Journal:  mBio       Date:  2019-06-25       Impact factor: 7.867

4.  Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells.

Authors:  Eric Carlin; Braxton Greer; Kelsey Lowman; Alexandra Duverger; Frederic Wagner; David Moylan; Alexander Dalecki; Shekwonya Samuel; Mildred Perez; Steffanie Sabbaj; Olaf Kutsch
Journal:  PLoS Pathog       Date:  2021-01-19       Impact factor: 6.823

5.  Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.

Authors:  Pejman Mohammadi; Julia di Iulio; Miguel Muñoz; Raquel Martinez; István Bartha; Matthias Cavassini; Christian Thorball; Jacques Fellay; Niko Beerenwinkel; Angela Ciuffi; Amalio Telenti
Journal:  PLoS Pathog       Date:  2014-05-29       Impact factor: 6.823

Review 6.  HIV-1 Latency and Latency Reversal: Does Subtype Matter?

Authors:  Indra Sarabia; Alberto Bosque
Journal:  Viruses       Date:  2019-11-28       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.